Drugs / cDC1 Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07694986 | Aug 2026 → Aug 2029 expected | breast cancer, neoplastic meningitis | H. Lee Moffitt Cancer Center and Research Institute | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cDC1 Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07694986 ↗ |
| Modality | Vaccine | “Autologous peptide-pulsed cDC1 vaccine administered intrathecally.” NCT07694986 ↗ |
| Route | Intrathecal | “Autologous peptide-pulsed cDC1 vaccine administered intrathecally.” NCT07694986 ↗ |